PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item
24. Indemnification of Directors and Officers
Section
145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other
employees and individuals against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings
in which such person is made a party by reason of such person being or having been a director, officer, employee or agent of the
corporation. Section 145 of the Delaware General Corporation Law also provides that expenses (including attorneys’ fees)
incurred by a director or officer in defending an action may be paid by a corporation in advance of the final disposition of an
action if the director or officer undertakes to repay the advanced amounts if it is determined such person is not entitled to
be indemnified by the corporation. The Delaware General Corporation Law provides that Section 145 is not exclusive of other rights
to which those seeking indemnification may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors
or otherwise. The provision does not affect directors’ responsibilities under any other laws, such as the federal securities
laws. The Company’s Certificate of Incorporation provides for such indemnification to the fullest extent of Section 145
and states that the indemnification is not exclusive of other rights of those seeking indemnification may be entitled.
Section
102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a
director of the corporation shall not be personally liable to the corporation or its shareholders for monetary damages for breach
of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the corporation
or its shareholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation
of law, (iii) for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for
any transaction from which the director derived an improper personal benefit. The Company’s Certificate of Incorporation
provides for such limitation of liability.
The Company has entered into agreements with
its directors and executive officers, that require the Company to indemnify such persons to the fullest extent permitted by law,
against expenses, judgments, fines, settlements and other amounts incurred (including attorneys’ fees), and advance expenses
if requested by such person, in connection with investigating, defending, being a witness in, participating, or preparing for
any threatened, pending, or completed action, suit, or proceeding or any alternative dispute resolution mechanism, or any inquiry,
hearing or investigation (collectively, a “Proceeding”), relating to any event or occurrence that takes place either
prior to or after the execution of the indemnification agreement, related to the fact that such person is or was a director or
officer of the Company, or while a director or officer is or was serving at the request of the Company as a director, officer,
employee, trustee, agent or fiduciary of another foreign or domestic corporation, partnership, joint venture, employee benefit
plan, trust or other enterprise, or was a director, officer, employee or agent of a foreign or domestic corporation that was a
predecessor corporation of the Company or of another enterprise at the request of such predecessor corporation, or related to
anything done or not done by such person in any such capacity, whether or not the basis of the Proceeding is alleged action in
an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer,
employee, or agent of the Company. Indemnification is prohibited on account of any Proceeding in which judgment is rendered against
such persons for an accounting of profits made from the purchase or sale by such persons of securities of the Company pursuant
to the provisions of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of any federal, state
or local laws. The indemnification agreements also set forth certain procedures that apply in the event of a claim for indemnification
thereunder.
The
Company maintains insurance on behalf of any person who is or was a director, officer or employee of the Company, or is or was
serving at the request of the Company as a director, officer, employee or agent of another company, partnership, joint venture,
trust or other enterprise against liability asserted against him and incurred by him in any such capacity, or arising out of his
status as such, whether or not the Company would have the power to indemnify him against liability under the provisions of this
section.
The
right of any person to be indemnified is subject always to the right of the Company by its board of directors, in lieu of such
indemnity, to settle any such claim, action, suit or proceeding at the expense of the Company by the payment of the amount of
such settlement and the costs and expenses incurred in connection therewith.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities
and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In
the event that a claim for indemnification against such liabilities (other than the payment of expenses incurred or paid by a
director, officer or controlling person in a successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, we will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to the court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.
At
present, there is no pending litigation or proceeding involving any of our directors, officers or employees as to which indemnification
is sought, nor are we aware of any threatened litigation or proceeding that may result in claims for indemnification.
Item
25. Other Expenses of Issuance and Distribution
The
following table sets forth the costs and expenses payable by us in connection with the offering of the common stock being registered.
All amounts are estimates. The selling shareholders will pay none of the expenses set forth below.
SEC filing fees
|
|
$
|
2,504
|
|
Legal fees and expenses
|
|
|
15,000
|
|
Accounting fees and expenses
|
|
|
2,500
|
|
Transfer agent fees and expenses
|
|
|
100
|
|
Printing fees
|
|
|
2,500
|
|
Miscellaneous
|
|
|
2,000
|
|
Total
|
|
$
|
24,604
|
|
Item
26. Recent Sales of Unregistered Securities
The
following sets forth all sales of unregistered securities we have completed during the last three years. Except as otherwise indicated
below, the following transactions were effected in reliance upon the exemption from registration set forth in Section 4(2) of
the Securities Act. We based such reliance upon the following facts and circumstances: (i) the investors were accredited investors,
as defined in Rule 501 of the Securities Act and were sophisticated, having sufficient knowledge and experience in financial and
business matters to make them capable of evaluating the merits and risks of the investment, (ii) the investors represented that
they were purchasing the securities for investment purposes without a view to distribution, (iii) the investors had access to
our management and information concerning the Company, its business and financial information and (iv) we conducted the sale of
the securities without general solicitation or advertising. Except as otherwise indicated below, no underwriting discounts or
commissions were paid in the transactions.
On
November 23, 2016, the Company entered into a securities purchase agreement and investor rights agreement with Unibel, the majority
shareholder of Bel Group (“Unibel”). Pursuant to the securities purchase agreement, Unibel purchased 15,625,000 shares
of common stock at $0.64 per share and warrants to purchase 7,812,500 shares of common stock for aggregate gross proceeds to Barfresh
of $10 million. The warrants are exercisable for a term of five years at a per share price of $0.88 for cash. The shares and common
stock issuable upon exercise of the warrants have the registration rights set forth in the investor rights agreement between the
Company and purchasers.
Pursuant to a securities purchase
agreement between the Company and certain accredited investors, in September, 2016 and October, 2016, the Company sold 4,687,500
shares of common stock and warrants to purchase 2,343,750 shares of common stock for aggregate gross proceeds to the Company of
approximately $2.3 million. The warrants are exercisable for a term of five years at a per share price of $0.75. The shares and
common stock issuable upon exercise of the warrants have the registration rights set forth in a registration rights agreement
between the Company and purchasers.
On
January 29, 2016, we closed a private placement to accredited investors of $2,670,000 in promissory notes and warrants to purchase
up to 1,297,500 shares of common stock of the Company for aggregate gross proceeds to the Company of $2,670,000. Of the aggregate
offering amount, $635,000 of the notes and warrants to purchase up to 317,500 shares of common stock were placed with members
of the Company’s management, including officers and directors of the Company, and family members of certain officers and
directors.
During
the three months ended September 30, 2015 we granted 80,000 options to purchase shares of our common stock to officers, directors
and employees. The exercise prices range from $0.47 to $0.72.
During
the three months ended June 30, 2015 we granted the right to 1,000,000 shares of restricted common stock to a director of the
Company who during the period became an officer of the Company. The stock vests 50% on each of the second and third anniversary
of the issuance. In addition, we granted the right to 350,000 shares of restricted to another officer in connection with an employment
agreement entered into during the three month period ended June 30, 2015.
During
the three months ended June 30, 2015, we issued 1,740,000 options to purchase our common stock to officers and employees of the
Company. The exercise price of the options ranged from $0.50 to $0.82 per share, and the options are exercisable for periods of
between 5 and 8 years. The options vest under a variety of vesting schedules. Two hundred sixty five thousand (265,000) of the
options vest on the first anniversary of issuance, 675,000 of the options vest on the second anniversary of issuance, 675,000
of the options vest on the third anniversary of issuance, and 125,000 of the options vest on the third anniversary of issuance.
During
the year ended March 31, 2015 we completed two offerings of common stock units at a price of $0.50 per unit. Each unit consists
of one share of common stock and a five year warrant to purchase one-half (1/2) share of our common stock at an exercise price
of $0.60 per share. We sold a total of 11,044,000 units representing 11,044,000 shares and warrants to purchase 5,522,000 shares
for total consideration of $5,522,000.
During
the year ended March 31, 2015 we issued 900,000 shares of restricted common stock to an officer and two employees of the Company
for services rendered.
Also
during the year ended March 31, 2015, we issued 155,000 shares of our restricted common stock to legal counsel and a consultant
to the Company.
Additionally,
during the year ended March 31, 2015, we issued 64,100 shares of our common stock to a director. The shares vest over a one year
period. We also issued options to purchase 600,000 shares of our common stock at an exercise price of $0.45 per share to two officers
and directors and a director of the Company. The options vested immediately and are exercisable for a period of 5 years from the
date of issuance, January 21, 2014.
During
November 2014 we issued 494,000 shares of our common stock for total consideration of $247,000. In addition to the Common Stock,
the Company issued 247,000 warrants to purchase shares of the Company’s common stock for a purchase price of $0.60 per share
and for a term of 5 years.
On
March 20, 2014 we completed a private placement to accredited investors of 5,000,000 shares of common stock and Series E Warrants
to purchase up to 2,500,000 shares for aggregate gross proceeds to the Company of $2,500,000. The Series E Warrants are exercisable
for a term of three-years at a per share price of $0.60. An additional 25,000 shares of common stock and Series E Warrants to
purchase 25,000 shares were issued to a service provider.
During
the year ended March 31, 2014 we issued 600,000 shares of common stock to officers and directors of the Company for services rendered.
We also issued 55,000 shares of our common stock to non-employees for consulting services and options to purchase 800,000 shares
of our common stock at an exercise price of $0.50 per share to a director of the Company. The options vested immediately and are
exercisable for a period of 3 years from the date of issuance, February 14, 2014.
On
December 20, 2013 we completed a private offering of an aggregate of $775,000 in promissory notes. The notes bear interest at
a rate of 2.0% and are due and payable on December 20, 2014, with certain provisions for extension. In addition to the notes,
the Company issued to the holders five-year warrants to purchase 1,291,667 shares of the Company’s common stock for a purchase
price of $0.45 per share.
On
August 7, 2013 we completed a private placement of 7,626,000 units at a purchase price of $0.25 per unit for a total aggregate
amount of $1,906,500. Each unit consists of one share of common stock, one three-year Series C Warrant to purchase a share of
common stock at a purchase price of $0.25 per share, and one five-year Series D Warrant to purchase one-half share of common stock
at a purchase price of $0.25 per one-half share ($0.50 per share). Network 1 Financial Securities, Inc., a licensed broker dealer,
acted as placement agent and received a selling commission equal to $190,650 and non-accountable expense reimbursement of $57,195.
Item
27. Exhibits
(
b)
|
Exhibits
required by Item 601 of Regulation S-K
|
Exhibit
Number
|
|
Description
|
2.1
|
|
Share
Exchange Agreement dated January 10, 2012 by and among Moving Box Inc., Andreas Wilcken, Jr., Barfresh Inc. and the shareholders
of Barfresh Inc. (incorporated by reference to Exhibit 2.1 to Current Report on Form 8-K as filed January 17, 2012
|
3.1
|
|
Certificate
of Incorporation of Moving Box Inc. dated February 25, 2010 (incorporated by reference to Exhibit 3.1 to Form S-1 (Registration
No. 333-168738) as filed August 11, 2010)
|
3.2
|
|
Amended
and Restated Bylaws of Barfresh Food Group Inc. (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K as
filed August 4, 2014)
|
3.3
|
|
Certificate
of Amendment of Certificate of Incorporation of Moving Box Inc. dated February 13, 2012 (incorporated by reference to Exhibit
3.1 to Current Report on Form 8-K as filed February 17, 2012)
|
3.4
|
|
Certificate
of Amendment of Certificate of Incorporation of Smoothie Holdings Inc. dated February 16, 2012 (incorporated by reference
to Exhibit 3.2 to Current Report on Form 8-K as filed February 17, 2012)
|
4.1
|
|
Form
of Series A Warrant (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K as filed January 17, 2012)
|
4.2
|
|
Form
of Series B Warrant (incorporated by reference to Exhibit 4.2 to Form 10K for the period ending March 31, 2014, as filed June
30, 2014)
|
4.3
|
|
Form
of Series C Warrant (incorporated by reference to Exhibit 4.3 to Form 10K for the period ending March 31, 2014, as filed June
30, 2014)
|
4.4
|
|
Form
of Series D Warrant (incorporated by reference to Exhibit 4.4 to Form 10K for the period ending March 31, 2014, as filed June
30, 2014)
|
4.5
|
|
Form
of Series PA Warrant (incorporated by reference to Exhibit 4.5 to Form 10K for the period ending March 31, 2014, as filed
June 30, 2014)
|
4.6
|
|
Form
of Series CN Warrant (incorporated by reference to Exhibit 4.6 to Form 10K for the period ending March 31, 2014, as filed
June 30, 2014)
|
4.7
|
|
Form
of Series EN Warrant (incorporated by reference to Exhibit 4.7 to Registration Statement
on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
4.8
|
|
Form
of Series E Warrant (Incorporated by reference to Exhibit 3.8 to Registration Statement on Form S-1 (Registration No. 333-203340)
as filed April 10, 2015)
|
4.9
|
|
Form
of Series G Warrant (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K as filed February 16, 2015)
|
4.10
|
|
Form
of Series H Warrant (incorporated by reference to Exhibit 4.10 to Registration Statement
on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
4.11
|
|
Form
of Series I Warrant (incorporated by reference to Exhibit 4.11 to Registration Statement
on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
4.12
|
|
Form
of Convertible Promissory Note dated January 29, 2016 by Barfresh Food Group Inc. in favor of certain investors (incorporated
by reference to Exhibit 4.12 to Registration Statement on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
4.13
|
|
Form
of warrant dated December 1, 2013 (incorporated by reference to Exhibit 4.13 to Registration
Statement on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
4.14
|
|
Form
of Series K Warrant*
|
4.15
|
|
Form
of Series J Warrant*
|
5.1
|
|
Opinion
and Consent of Libertas Law Group, Inc.*
|
10.1
|
|
Form
of Registration Rights Agreement dated February 16, 2016 (incorporated by reference to
Exhibit 10.1 to Registration Statement on Form S-1 (Registration No. 333-211019) as filed
April 29, 2016)
|
10.2
|
|
Intellectual
Property Sale Deed by and between National Australia Bank Limited and Barfresh Inc. dated October 15, 2013 (incorporated by
reference to Exhibit 10.1 to Quarterly Report on Form 10-Q as filed November 20, 2013)
|
10.3
|
|
Form
of Securities Purchase Agreement dated February 16, 2016 by and between Barfresh Food Group Inc. and certain investors. (incorporated
by reference to Exhibit 10.3 to Registration Statement on Form S-1 (Registration No. 333-211019) as filed April 29, 2016)
|
10.4
|
|
Form
of Investor Rights Agreement dated November 23, 2016 by and between Barfresh Food Group,
Inc. and Unibel*
|
10.5
|
|
Form
of Securities Purchase Agreement dated November 23, 2016 by and between Barfresh Food
Group, Inc. and Unibel*
|
10.6
|
|
Form
of Securities Purchase Agreement dated September 28, 2016 by and between Barfresh Food
Group, Inc. and certain investors*
|
10.7
|
|
Form
of Registration Rights Agreement dated September 28, 2016 by and between Barfresh Food
Group, Inc. and certain investors*
|
21.1
|
|
Subsidiaries
(Incorporated by reference to Exhibit 21.1 to Transitional Report on Form 10KT for the transitional period from April 1, 2015
to December 31, 2015, filed on March 30, 2016)
|
23.1
|
|
Consent
of Eide Bailly LLP+
|
23.2
|
|
Consent
of Libertas Law Group, Inc. (included in Exhibit 5.1)*
|
*
Previously filed with this registration statement on Form S-1.
+Filed herewith.
Item
28. Undertakings
The
undersigned registrant hereby undertakes:
1.
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
a.
To include any prospectus required by Section 10(a)(3) of the Securities Act;
b.
To reflect in the prospectus any facts or events which, individually or together, represent a fundamental change in the information
in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in the volume and rise represent no more than a 20% change in the maximum aggregate offering
price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
c.
To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement
or any material changes to such information in the Registration Statement.
2.
For determining liability under the Securities Act, treat each post-effective amendment as a new registration statement of the
securities offered, and the offering of the securities at that time to be the initial bona fide offering.
3.
To file a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering.
4.
For determining liability of the undersigned issuer under the Securities Act to any purchaser in the initial distribution of the
securities, the undersigned issuer undertakes that in a primary offering of securities of the undersigned issuer pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned issuer will be a seller
to the purchaser and will be considered to offer or sell such securities to such purchaser:
i.
Any preliminary prospectus or prospectus of the undersigned issuer relating to the offering required to be filed pursuant to Rule
424;
ii.
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned issuer or used or referred to
by the undersigned issuer;
iii.
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
issuer or its securities provided by or on behalf of the undersigned issuer; and
iv.
Any other communication that is an offer in the offering made by the undersigned issuer to the purchaser.
5.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer of controlling person of the Registrant in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.
6.
For determining any liability under the Securities Act, treat the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant under
Rule 424(b)(1) or (4) or 497(h) under the Securities Act as part of this registration statement as of the time the Commission
declared it effective.
7.
For determining any liability under the Securities Act, treat each post-effective amendment that contains a form of prospectus
as a new registration statement for the securities offered in the registration statement, and that offering of the securities
at that time as the initial bona fide offering of those securities.
8.
That, for the purpose of determining liability under the Securities Act to any purchaser:
a.
If the issuer is relying on Rule 430B:
1.
Each prospectus filed by the undersigned issuer pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement
as of the date the filed prospectus was deemed part of and included in the registration statement; and
2.
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information
required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of
the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any
person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement
relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by
reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with
a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date;
or
b.
If the issuer is subject to Rule 430C: Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating
to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A,
shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part
of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such date of first use.